Skip to main content

Increase exposure of your key findings

Your drug development program has overcome many challenges and required a substantial investment to get to this point. Increase exposure of your program’s key findings and accelerate buy-in among healthcare providers and the scientific community with high quality scientific outputs.

Certara’s Synchrogenix team offers advanced publication planning and writing support for scientific and medical writings across all phases of drug development. IN need of flexibility? Our scalable resources provide strategic expertise and execution to deliver quality publications from start to decision, working closely with internal client authoring teams and external stakeholders.

 “Appreciate your hard work to drive our manuscript to full acceptance.” – Associate Director of Medical Communications at a Fortune 500 pharmaceutical company

Expert support for you scientific and medical communication needs

Our scientific medical writers have experience in over 100 indications in various therapeutic areas. We have deep expertise in communicating the treatment benefits in rare diseases, PK/PD analysis, and biomarker studies. Our writers have advanced degrees, 20+ years’ experience, and many have additional industry-recognized certifications, such as ELS and CMPP.

• Maximize the probability of acceptance decisions with our
outstanding writing support and process guidance.
• Mitigate your risk of potential misrepresentations across geographies and cultures with Certara’s global team
• Alleviate your internal burden with a team that owns and accelerates project timelines

As key opinion leaders, Synchrogenix medical writers speak regularly at major industry events such as various DIA meetings, ISMPP, and AMWA’s Medical Writing and Communication Conference.

Download brochure
Expert support for you scientific and medical communication needs
Wide range of services to support medical and scientific, communications and publications

Wide range of services to support medical and scientific, communications and publications

Over the past year, we have supported client manuscripts across a variety of therapeutic areas including immunology, neuroscience,  oncology, and rare disease that were published in journals including:

  • Journal of Drugs in Dermatology
  • Clinical Rheumatology
  • Cephalalgia
  • Journal of Managed Care & Specialty Pharmacy
  • Cancer
  • European Journal of Neurology
  • Current Medical Research and Opinion
  • Journal of Pharmacology and Experimental Therapeutics
  • Journal of Medical Economics
  • Brain
  • Journal of Alzheimer’s Disease
Start a conversation

Flexible and scalable resource pools when you need them

With full-time teams in North America, Europe and Asia-Pacific, Certara, provides 24-hour support and the flexibility and scalability required for rapid response to your most urgent needs.

We handle the administrative burden of on-boarding team members so that you can focus on engaging our highly skilled medical writers without stress or delay.

Certara has the expertise you need for all your writing needs. Want help with your regulatory submissions from early stage INDs to NDAs, and MAAs? Our regulatory writers have the expertise to support you across the full drug development lifecycle. Likewise, our transparency and disclosure experts can help you enhance patient engagement, meet regulatory disclosure requirements, and maintain compliance.

Contact us
Flexible and scalable resource pools when you need them
Linda Tabas
Linda Tabas Director, Medical Publications & Communications

Linda has over 30 years of experience in scientific communications and publishing. Prior to joining Certara, she was a scientific writing, communications consultant at Eli Lilly, overseeing medical publications supported by TPOs.

Capasso Harris headshot
Holly Capasso-Harris, PhD Senior Medical Writer, Synchrogenix Regulatory Science

Holly has a PhD in cell and molecular pharmacology and more than 18 years of experience in medical writing and as an editor. She has written over 80 abstracts, posters, and manuscripts based on preclinical and clinical data in a wide range of therapeutic areas. Before joining Certara, she worked with several medical communications agencies servicing a variety of pharmaceutical and biotechnology companies and professional medical associations.